How do you pay?

How to pay the least

Ask for the cash price

Osenvelt

Osenvelt is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.

  1. Ask your pharmacy for Osenvelt’s cash price, and one or two other pharmacies too.
  2. Osenvelt’s savings card works only with insurance from a job or one you bought.

Compare every option

Question
Brand nameOsenvelt
Authorized genericdenosumab-bmwo
Regular genericdenosumab-bmwo
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldAsk the pharmacy
Same as Osenvelt?
The original
–
–

Brand nameThe maker’s card

Celltrion CARES Co-pay Assistance Program

Savings card from Celltrion

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a dose

Sign up on celltrionconnect.com 

In the maker’s words

“Patients may pay as little as $0 for each dose of OSENVELT…”

From the maker’s offer on celltrionconnect.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Osenvelt itself, from the same company, sold without the brand name, and usually for less. For now Osenvelt is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

Osenvelt is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

Osenvelt is a RANK ligand (RANKL) inhibitor indicated for:

  • Prevention of skeletal-related events in patients with multiple myeloma and in patients with bone metastases from solid tumors.
  • Treatment of adults and skeletally mature adolescents with giant cell tumor of bone that is unresectable or where surgical resection is likely to result in severe morbidity.
  • Treatment of hypercalcemia of malignancy refractory to bisphosphonate therapy.

Source: the FDA label for Osenvelt (CELLTRION USA, Inc.), February 5, 2026. Full label on DailyMed 

Good to know